Effects of Peas on Blood Glucose Control
A Randomized, Controlled, Cross-over Trial Examining the Effect of Peas on Post-prandial Glucose Response in Healthy Adults
1 other identifier
interventional
64
1 country
1
Brief Summary
Diabetes is one of the most common chronic diseases affecting Canadians (PHAC, 2011). Lifestyle modifications that include a diet high in fibre may lower the risk of developing type 2 diabetes (CDA, 2013). In this context, the presence of fibre in carbohydrate rich foods has been widely recognized for its effect on post-prandial glucose response (PPGR). Peas are high in fibre and protein and show great potential as a functional food. A health claim for PPGR would increase market demand for peas, and help those who want to limit the rise in blood sugar after a meal choose products to meet their goals, but there are several gaps in the literature that need to be filled before a submission to Health Canada can be successful: 1) test foods in appropriate serving sizes; 2) test both the glucose and insulin response; 3) test varieties of peas that that currently available on the market; 4) test whole/split peas (not fractions or isolates); 5) compare peas to appropriate starchy reference food (rice or potato). The proposed study design will address all of these gaps in the current literature and take into consideration Health Canada's guidance document for health claims related to the reduction in PPGR, which sets out the criteria by which the validity of such claims will be assessed. Specific objectives
- 1.To determine the effect of 3 common market classes of peas on PPGR and insulin response in a cross-over, randomized, controlled clinical trial.
- 2.To assess the effect of 3 common market classes of peas on appetite-related sensations using visual analog scales.
- 3.To demonstrate whether the test and reference products were liked or disliked similarly by participants.
- 4.To assess any gastrointestinal side effects from eating the test products
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 27, 2015
CompletedFirst Posted
Study publicly available on registry
September 17, 2015
CompletedStudy Start
First participant enrolled
October 16, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 14, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2025
CompletedFebruary 2, 2024
January 1, 2024
1.8 years
July 27, 2015
January 31, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Postprandial blood glucose
samples collected to test glucose at fasting and at 15,30,45,60,90 and 120 minutes after the first bite of the test product
up to 2 hours following a meal
Postprandial blood insulin
samples collected to test insulin at fasting and at 15,30,45,60,90 and 120 minutes after the first bite of the test product
up to 2 hours following a meal
Secondary Outcomes (3)
Hunger (Visual analogue scales)
up to 2 hours following a meal
Fullness (Visual analogue scales)
up to 2 hours following a meal
Desire to eat (Visual analogue scales)
up to 2 hours following a meal
Other Outcomes (2)
Acceptability of test products based on sensory scales
immediately after eating test product
Gastrointestinal side effects
up to 24 hours following a meal
Study Arms (10)
White bread 1
PLACEBO COMPARATORGroups 1 and 2, Visit 1 White bread (equal to 50g available carbohydrate) given to fasting participant
Pea variety 1 with rice
EXPERIMENTALGroup 1,Visit 2-5 Pea variety 1 with rice (25g available carbohydrate of each) given as breakfast to fasting participants
Pea variety 2 with rice
EXPERIMENTALGroup 1, Visit 2-5 Pea variety 2 with rice (25g available carbohydrate of each) given as breakfast to fasting participants
Pea variety 3 with rice
EXPERIMENTALGroup 1, Visit 2-5 Pea variety 3 with rice (25g available carbohydrate of each) given as breakfast to fasting participants
Rice
EXPERIMENTALGroup 1, Visit 2-5 Rice (equal to 50g available carbohydrate) given as breakfast to fasting participants
White bread 2
PLACEBO COMPARATORGroups 1 and 2, Visit 6 White bread (equal to 50g available carbohydrate) given to fasting participant
Pea variety 1 with potato
EXPERIMENTALGroup 2, Visit 2-5 Pea variety 1 with potato (25g available carbohydrate of each) given as breakfast to fasting participants
Pea variety 2 with potato
EXPERIMENTALGroup 2, Visit 2-5 Pea variety 2 with potato (25g available carbohydrate of each) given as breakfast to fasting participants
Pea variety 3 with potato
EXPERIMENTALGroup 2, Visit 2-5 Pea variety 3 with potato (25g available carbohydrate of each) given as breakfast to fasting participants
Potato
EXPERIMENTALGroup2, Visit 2-5 Potato (equal to 50g available carbohydrate) given as breakfast to fasting participants
Interventions
Eligibility Criteria
You may qualify if:
- Generally healthy male or female, between the age of 18-40 years;
- Body mass index (BMI) 18.5-34.5 kg/m2;
- HbA1c \<6.0%;
- Willing to provide informed consent;
- Willing/able to comply with the requirements of the study.
You may not qualify if:
- Pregnant or lactating;
- Medical history of diabetes mellitus, fasting plasma glucose ≥7.0 mmol/L or use of insulin or oral medication to control blood sugar;
- Medical history of cardiovascular disease
- Systolic blood pressure \>140 mmHg or diastolic blood pressure \>90 mmHg;
- Fasting plasma total cholesterol \>7.8 mmol/L;
- Fasting plasma HDL \<0.9 mmol/L;
- Fasting plasma LDL \>5.0 mmol/L;
- Fasting plasma triglycerides \>2.3 mmol/L;
- A change in blood glucose concentration less than 1 mmol/L between baseline and 30 minutes after consumption of white bread at visit 1;
- Maximum blood glucose concentration occurs after 60 minutes after consumption of white bread at visit 1;
- Major surgery within the last 3 months;
- Medical history of inflammatory disease (ie. Systemic lupus erythematosis, rheumatoid arthritis, psoriasis) or use of any corticosteroid medications within 3 months;
- Medical history of liver disease or liver dysfunction (defined as plasma AST or ALT ≥1.5 times the upper limit of normal (ULN));
- Medical history of kidney disease or kidney dysfunction (defined as blood urea nitrogen and creatinine ≥ 1.8 times the ULN));
- Presence of a gastrointestinal disorder, daily use of any stomach acid-lowering medications or laxatives (including fibre supplements) within the past month or antibiotic use with the past 6 weeks;
- +10 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- St. Boniface Hospitallead
- Agriculture and Agri-Food Canadacollaborator
Study Sites (1)
I. H. Asper Clinical Research Institute
Winnipeg, Manitoba, R2H 2A6, Canada
Related Publications (8)
Hamberg O, Rumessen JJ, Gudmand-Hoyer E. Blood glucose response to pea fiber: comparisons with sugar beet fiber and wheat bran. Am J Clin Nutr. 1989 Aug;50(2):324-8. doi: 10.1093/ajcn/50.2.324.
PMID: 2547300BACKGROUNDMarinangeli CP, Jones PJ. Chronic intake of fractionated yellow pea flour reduces postprandial energy expenditure and carbohydrate oxidation. J Med Food. 2011 Dec;14(12):1654-62. doi: 10.1089/jmf.2010.0255.
PMID: 22145774BACKGROUNDMarinangeli CP, Kassis AN, Jones PJ. Glycemic responses and sensory characteristics of whole yellow pea flour added to novel functional foods. J Food Sci. 2009 Nov-Dec;74(9):S385-9. doi: 10.1111/j.1750-3841.2009.01347.x.
PMID: 20492127BACKGROUNDMollard RC, Wong CL, Luhovyy BL, Cho F, Anderson GH. Second-meal effects of pulses on blood glucose and subjective appetite following a standardized meal 2 h later. Appl Physiol Nutr Metab. 2014 Jul;39(7):849-51. doi: 10.1139/apnm-2013-0523. Epub 2014 May 5.
PMID: 24797207BACKGROUNDMollard RC, Zykus A, Luhovyy BL, Nunez MF, Wong CL, Anderson GH. The acute effects of a pulse-containing meal on glycaemic responses and measures of satiety and satiation within and at a later meal. Br J Nutr. 2012 Aug;108(3):509-17. doi: 10.1017/S0007114511005836. Epub 2011 Nov 7.
PMID: 22054112BACKGROUNDMollard RC, Wong CL, Luhovyy BL, Anderson GH. First and second meal effects of pulses on blood glucose, appetite, and food intake at a later meal. Appl Physiol Nutr Metab. 2011 Oct;36(5):634-42. doi: 10.1139/h11-071. Epub 2011 Sep 29.
PMID: 21957874BACKGROUNDSchafer G, Schenk U, Ritzel U, Ramadori G, Leonhardt U. Comparison of the effects of dried peas with those of potatoes in mixed meals on postprandial glucose and insulin concentrations in patients with type 2 diabetes. Am J Clin Nutr. 2003 Jul;78(1):99-103. doi: 10.1093/ajcn/78.1.99.
PMID: 12816777BACKGROUNDSievenpiper JL, Kendall CW, Esfahani A, Wong JM, Carleton AJ, Jiang HY, Bazinet RP, Vidgen E, Jenkins DJ. Effect of non-oil-seed pulses on glycaemic control: a systematic review and meta-analysis of randomised controlled experimental trials in people with and without diabetes. Diabetologia. 2009 Aug;52(8):1479-95. doi: 10.1007/s00125-009-1395-7. Epub 2009 Jun 13.
PMID: 19526214BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Heather J Blewett, PhD
Agriculture and Agri-Food Canada
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 27, 2015
First Posted
September 17, 2015
Study Start
October 16, 2015
Primary Completion
August 14, 2017
Study Completion
January 1, 2025
Last Updated
February 2, 2024
Record last verified: 2024-01